Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Feb 2, 2017Click on the links below to view results for 2017 First Fiscal Quarter:
View Document Online PDF File of BD 2017 First Fiscal Quarter Results About BD BD is one of the largest global medical technology companies in the world and is advancing the world of health by...
-
Jan 26, 2017BD Launches New Initiative to Drive Simpler, Safer and Cost-Effective Medication Management
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of its new BD Institute for Medication Management Excellence, developed to...
-
Jan 23, 2017Indication for Congestive Heart Failure on Display at the 2017 Society of Thoracic Surgeons (STS) Meeting
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced its PleurX(TM) catheter system received U.S. Food and Drug Administration (FDA) 510(k)...
-
Jan 23, 2017
Franklin Lakes, NJ (January 23, 2017) - The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of 73 cents per common share, payable on March...
-
Jan 20, 2017New Framework Provides Recommendations for Optimizing Diagnostic Solutions to Combat AMR
Davos-Klosters, Switzerland - AdvaMedDx, the association representing manufacturers of diagnostic tests to promote wellness, improve patient outcomes, and advance public health, today announced a...
-
Jan 18, 2017
Franklin Lakes, NJ (January 18, 2017) - BD (Becton, Dickinson and Company) (NYSE:BDX), a global medical technology company, announced today that it will host a live webcast of its Annual Meeting...
-
Jan 17, 2017Precise WTA Reagents Provide Accurate, Simple Quantification of Genetic Information in Individual Cells
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the commercial availability of its new kits that provide an easier method to identify...
-
Jan 12, 2017Top 100 most innovative companies shift focus from quantity to quality
PHILADELPHIA, January 10, 2017 - Clarivate Analytics, formerly the Intellectual Property & Science business of Thomson Reuters, today announced its highly anticipated list of 2016 Top 100 Global...
-
Jan 11, 2017
Franklin Lakes, NJ (January 11, 2017) - Franklin Lakes, NJ (January 11, 2017) - BD(Becton, Dickinson and Company)(NYSE:BDX) announced today that it will conduct a live webcast of its first fiscal...
-
Jan 9, 2017
BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the 35th Annual J. P. Morgan Healthcare Conference on Wednesday,...
-
Jan 9, 2017
Franklin Lakes, NJ (January 9, 2017) - BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the 35th Annual J. P....
-
Dec 19, 2016
Singapore, 19 December 2016 - SSON Analytics, the global data analytics centre of the Shared Services & Outsourcing Network (SSON), has today announced the launch of a new benchmarking study with...
-
Dec 15, 2016New BD Neopak(TM) 2.25 mL Prefillable Glass Syringe Helps Improve Safety and Convenience for Patients
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of the BD Neopak(TM) 2.25 mL prefillable glass syringe, specifically...
-
Dec 9, 2016
FRANKLIN LAKES, N.J. - BD (Becton, Dickinson and Company) today issued the following statement to congratulate Dr. John Nkengasong on his appointment as the first director of the newly established...
-
Dec 5, 2016Experience the Difference of Enterprise-wide Medication Management at #ASHP16 Midyear Meeting
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, will demonstrate an enhanced technology platform designed with the ability to synchronize BD medication...
-
Dec 1, 2016New Operating System Offers Health Systems Long-Term Medication Management Platform and Enhanced Cybersecurity
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced adoption of Windows 10 Internet of Things (IoT) operating system (OS) for its...
-
Nov 17, 2016
Franklin Lakes, NJ (November 14, 2016) - BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will host an institutional investor and analyst meeting on Thursday, November 17,...
-
Nov 17, 2016
Earnings Releases / Presentations About BD BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery,...
-
Nov 10, 2016BD to Showcase Latest Advancements at the 16th Annual Diabetes Technology Meeting
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company today announced a new research collaboration supported by JDRF, the leading global organization funding...
-
Nov 8, 2016BD and Lilly Diabetes Collaboration Offers New Delivery Solution for People with Insulin Resistance
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company announced today the launch of the BD(TM) U-500 Insulin Syringe, the first insulin syringe developed for...
-
Nov 3, 2016
Click on the links below to view results for 2016 Third Fiscal Quarter: View document online » PDF File of BD 2016 Third Fiscal Quarter Results » About BD BD is one of the largest global medical...
-
Oct 31, 2016Expands Reproductive and Sexually Transmitted Infections Portfolio with First Test Using Microbiome-based Algorithm for Bacterial Vaginosis Detection
FRANKLIN LAKES, N.J., Oct. 31, 2016 - BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced U.S. Food and Drug Administration (FDA) market...
-
Oct 4, 2016Apax Funds to be majority owner of new company, Vyaire Medical
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Apax Partners, today announced the launch of a joint venture - Vyaire Medical - a standalone,...
-
Sep 30, 2016New BD Phoenix(TM) M50 System delivers modularity, reliability, affordability and high-quality susceptibility results needed by clinical microbiology laboratories worldwide
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of its next generation diagnostic instrument for the rapid identification of...
- Sep 29, 2016The New BD Vacutainer® Barricor(TM) Tube Offers First Major Advance in Plasma Separation Technology in Decades
BD (Becton, Dickinson and Company), a leading global medical technology company, announced today that it received U.S. Food and Drug Administration (FDA) 510(k) clearance for the BD Vacutainer(®)...
-
Sep 22, 2016
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it is investing $100 million in its Holdrege, Neb. facility to expand capacity for its...
- Sep 21, 2016New BD Veritor(TM) Plus System Enables Fast and Accurate Test Results for Health Care Providers
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of its next generation wireless rapid diagnostic system for detection of...
-
Sep 16, 2016BD ChloraShield(TM) Dressings are Now Available for a Range of Vascular Access Procedures
BD (Becton, Dickinson and Company) (NYSE: BDX) and Vancive Medical Technologies(TM), an Avery Dennison (NYSE: AVY) business, today launched a line of transparent vascular dressings with...
-
Sep 13, 2016BD Obtains FDA Clearance for the BD MAX CT/GC/TV Assay on the BD MAX™ System
FRANKLIN LAKES, N.J., Sept. 13, 2016 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it obtained U.S. Food and Drug...
-
Sep 12, 2016Latest Release of Industry-Leading Pyxis ES platform Advances Enterprise-wide Medication Management and Patient Safety Across Continuum of Care
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced general availability of the latest software release of Pyxis(TM) ES System, delivering...
-
Sep 6, 2016
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it has submitted a pre-market approval (PMA) application to the U.S. Food and Drug...
-
Sep 1, 2016New Recommendations Based on Findings from Largest-Ever International Survey of more than 13,200 Insulin-Injecting Patients from 42 Countries
The prestigious medical journal, Mayo Clinic Proceedings , today published new insulin delivery recommendations for health care professionals caring for insulin-using patients, including the...
-
Aug 18, 2016Announces $20 Million Investment to Support Growth
SANDY, Utah, Aug. 18, 2016 /PRNewswire/ – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, was joined by senior public officials today to celebrate...
-
Aug 16, 2016Alaris(TM) System Also Cited as Most Comprehensive Infusion Platform
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that its Alaris(TM) System infusion platform was cited as having the most customers...
-
Aug 15, 2016
FRANKLIN LAKES, N.J., August 15, 2016 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received U.S. Food and Drug...
-
Aug 4, 2016
Click on the links below to view results for 2016 Third Fiscal Quarter: View document online » PDF File of BD 2016 Third Fiscal Quarter Results » About BD BD is one of the largest global medical...
-
Jul 28, 2016
FRANKLIN LAKES, N.J., JULY 26, 2016 – The Board of Directors BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of 66 cents per common share, payable on September...
-
Jul 28, 2016
FRANKLIN LAKES, N.J., JULY 28, 2016 – BD(Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that R. Andrew “Andy” Eckert has been...
-
Jul 19, 2016More than 100 Hospitals Have Implemented Interoperability for Alaris(TM) System
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that more than 100 hospitals and health systems have implemented the company's...
-
Jul 1, 2016
FRANKLIN LAKES, NJ July 1, 2016 – BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will conduct a live webcast of its third fiscal quarter 2016 earnings conference call on...
-
Jun 16, 2016
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a development and global distribution agreement with Check-Points for BD MAX(TM) assays...
-
May 26, 2016First Live Demonstration of the New Cell Sorter at Upcoming CYTO Annual Meeting
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, continues to reinforce its commitment to making flow cytometry easier and more affordable with the...
-
May 5, 2016
Click on the links below to view results for 2016 Second Fiscal Quarter: View document online » PDF File of BD 2016 Second Fiscal Quarter Results » About BD BD is one of the largest global...
-
Apr 26, 2016New BD U-40 Pet Syringes Available at Veterinary Offices
FRANKLIN LAKES, N.J., April 26, 2016 – BD (Becton, Dickinson and Company), a leading medical technology company, announced today that it has launched BD Pet Syringes – veterinary insulin...
-
Apr 22, 2016Genesis(TM) Low Temperature Rigid Sterilization Container System Validated for Modern Low-Temp Sterilization Practices
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a new line of surgical instrument sterilization containers that are validated for the...
-
Apr 21, 2016
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading medical technology company, announced today that it has sold its vertebral augmentation solutions business, which includes all AVAmax®,...
-
Mar 30, 2016
FRANKLIN LAKES, N.J., Mar. 30, 2016 – BD (Becton, Dickinson and Company), a leading global medical technology company, has obtained 510(k) clearance from the U.S. Food and Drug Administration...
-
Mar 15, 2016Marks sixth year in top spot for infection control and monitoring category
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading medical technology company, announced today that BD MedMined(®) Surveillance Advisor has been named a 2015/2016 Category Leader for...
-
Mar 8, 2016Apax Funds will be majority owner of new company
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a definitive agreement to sell 50.1 percent of its Respiratory Solutions business to...
-
Mar 7, 2016Adds BD Totalys(TM) MultiProcessor and BD Totalys(TM) SlidePrep for Gynecological Specimen Preparation to Cytology Instrumentation Portfolio
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received U.S. Food and Drug Administration (FDA) approval for its BD Totalys(TM)...
